“Marc has great experience in the space and his work product is excellent.”
— Chambers USA 2024
Marc Wagner focuses his practice on regulatory and transactional matters, primarily in the healthcare and life sciences industries. He advises companies and executives on Food and Drug Administration (FDA), Drug Enforcement Administration (DEA) and state board of pharmacy compliance and enforcement. Clients in the drug supply chain seek his strategic guidance on critical diligence, regulatory and litigation matters.
He helps drug manufacturers, pharmacies, wholesalers, outsourcing facilities and third-party logistics provider clients resolve complicated issues, including by advocating for clients before investigators, legislators and regulators. Marc is passionate about ending drug shortages and works with outsourcing facility clients on mitigation strategies and overall drug shortage policy.
Marc’s educational and professional background as a registered pharmacist provides him with a substantial understanding of a variety of pharmaceutical compliance and operational measures to prepare for and respond to inspection and enforcement action and government investigations. Marc is frequently involved in transactions to advise on transaction structure and securing operating licenses to avoid compliance actions from governmental agencies.